Lonza sees flurry of ADC technology licensing agreements
In the space of three weeks, the company has announced four separate antibody-drug conjugate deals with AmMax Bio, Antharis Therapeutics, InduPro, and Stipple Bio.
Read the full article on the original site.
Read Full Article